A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
A Phase 1, Open-Label Study in Healthy Participants to Investigate the Pharmacokinetics of Ritlecitinib Following Single Oral Administration of Modified Release Formulations Under Fed and Fasted Conditions
Category & Conditions: Gastrointestinal Disorders
Medicine: ritlecitinib (PF-06651600)
ClinicalTrials.gov Identifier (NCT): NCT06172348
Protocol ID: B7981086
Open Plain Language Summary Result:
Click here